Feb 24, 2020 8:30am EST Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020
Dec 20, 2019 8:30am EST Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines
Nov 20, 2019 8:30am EST Avalon GloboCare to Present at the 12th Annual LD Micro Main Event on December 10th
Sep 19, 2019 8:00am EDT Avalon GloboCare Announces Initiation of First-in-Human Clinical Trial of its CAR-T Candidate, AVA-001, for Treatment of B-Cell Malignancies
Sep 03, 2019 8:00am EDT Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman
Jul 15, 2019 8:00am EDT Avalon GloboCare Provides Updates on its Lead Clinical Programs in CAR-T Therapy and Exosome-Based Regenerative Therapeutics
Jun 26, 2019 8:30am EDT Avalon GloboCare Appoints Dr. Yen-Michael Sheng Hsu, Founding Director of cGMP Cellular Therapy Facility at Weill Cornell Medicine, to its Scientific and Clinical Advisory Board